Boardroom Alpha
10-K primary document
LMAT · Annual Report (Form 10-K) · Filed February 26, 2026

Lemaitre Vascular Inc10-K exhibit

ck0001158895-ex21_1.htm
EX-21.1

EXHIBIT 21.1

SUBSIDIARIES OF THE REGISTRANT

The following is a list of our subsidiaries:

 

Name

State or Other Jurisdiction

of Incorporation

Name Under Which Does Business

LeMaitre Vascular GmbH

Germany

Same

LeMaitre Vascular GK

Japan

Same

LeMaitre Acquisition LLC

Delaware

Same

LeMaitre Vascular SAS

France

Same

LeMaitre Vascular Spain, S.L.

Spain

Same

LeMaitre Vascular S.r.l.

Italy

Same

Vascutech Acquisition LLC

Delaware

Same

LeMaitre Vascular ULC

Canada

Same

LeMaitre Vascular Switzerland GmbH

Switzerland

Same

LeMaitre Vascular AS

Norway

Same

LeMaitre Vascular Pty Ltd

Australia

Same

LeMaitre Medical Technology (Shanghai) Co., Ltd

China

Same

LeMaitre Vascular, Ltd

United Kingdom

Same

Bio Nova Holdings Pty Ltd

Australia

Same

Bio Nova International Pty Ltd

Australia

Same

LeMaitre Cardial SAS

France

Same

LeMaitre Pte Ltd

Singapore

Same

LeMaitre Ltd

Korea

Same

LeMaitre Co., Ltd

Thailand

Same

LeMaitre Ireland Ltd

 

Ireland

 

Same

LeMaitre Acquisition Pty Ltd

 

Australia

 

Same

 


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer